Smart labels for drugs and medical devices, both after commercial launch and during clinical trials, do far more than simply identify a product; their built-in intelligence provides functionality, communication capabilities, and interactivity throughout the supply chain all the way to the end-user.

Featuring technology ranging from simple chemical-based visual indicators to more-cutting-edge radio frequency identification (RFID) and near field communication (NFC), today’s smart labels play a growing role in maintaining brand security, improving supply chains, improving the accuracy of clinical trials, connecting consumers to brand owners, gathering marketing intelligence, and ensuring consumer safety.